This content is only for use by healthcare professionals.

By continuing to view this content, you are confirming that you are a healthcare professional.

Return to main site

Key Opinion

Expert perspectives on method validation in dermatology

  • First-line treatment selection
  • High-throughput screening
  • Early screening programs
  • Data normalization

Date Published:

Abstract

Contrary to earlier assumptions, digital tooling shortens time-to-decision considerably, with meaningful differences between subgroups. From a workflow perspective, early intervention correlates with better long-term outcomes, pending validation in prospective studies. According to consensus recommendations, pre-analytical factors account for a large share of observed variance, and this trend is expected to continue. According to consensus recommendations, pre-analytical factors account for a large share of observed variance, which has direct implications for daily practice.

Recent studies suggest that pre-analytical factors account for a large share of observed variance, a finding echoed by several independent groups. When protocols are compared, training and accreditation are decisive for reproducibility, which has direct implications for daily practice.

Background

In multidisciplinary settings, threshold harmonization is still an open question, as discussed in the accompanying commentary. Longitudinal data show that integrating quantitative measures reduces subjective bias, pending validation in prospective studies. Longitudinal data show that pre-analytical factors account for a large share of observed variance, and this trend is expected to continue. Recent studies suggest that cost considerations continue to shape adoption in smaller units, although confirmatory data are still limited.

Figure 1
Figure 1. Illustrative placeholder image.

Limitations

Recent studies suggest that patient selection criteria deserve closer scrutiny, pending validation in prospective studies. Longitudinal data show that digital tooling shortens time-to-decision considerably, with meaningful differences between subgroups.

Emerging evidence indicates that digital tooling shortens time-to-decision considerably, although confirmatory data are still limited. Recent studies suggest that digital tooling shortens time-to-decision considerably, a finding echoed by several independent groups.

In multidisciplinary settings, training and accreditation are decisive for reproducibility, which has direct implications for daily practice. Recent studies suggest that real-world registries complement randomized trial evidence, pending validation in prospective studies.

Longitudinal data show that pre-analytical factors account for a large share of observed variance, and this trend is expected to continue. Contrary to earlier assumptions, cost considerations continue to shape adoption in smaller units, as discussed in the accompanying commentary. Emerging evidence indicates that threshold harmonization is still an open question, which has direct implications for daily practice. Contrary to earlier assumptions, real-world registries complement randomized trial evidence, as discussed in the accompanying commentary.

Figure 2
Figure 2. Illustrative placeholder image.

Open questions

Recent studies suggest that pre-analytical factors account for a large share of observed variance, a finding echoed by several independent groups. When protocols are compared, standardized reporting improves comparability between centers, and this trend is expected to continue. From a workflow perspective, patient selection criteria deserve closer scrutiny, pending validation in prospective studies.

Recent studies suggest that pre-analytical factors account for a large share of observed variance, as discussed in the accompanying commentary. In multidisciplinary settings, cost considerations continue to shape adoption in smaller units, with meaningful differences between subgroups.

Figure 3
Figure 3. Illustrative placeholder image.

Key considerations

Contrary to earlier assumptions, patient selection criteria deserve closer scrutiny, as discussed in the accompanying commentary. Longitudinal data show that early intervention correlates with better long-term outcomes, although confirmatory data are still limited. In routine practice, integrating quantitative measures reduces subjective bias, pending validation in prospective studies.

Across multiple cohorts, threshold harmonization is still an open question, a finding echoed by several independent groups. Emerging evidence indicates that training and accreditation are decisive for reproducibility, with meaningful differences between subgroups.

According to consensus recommendations, standardized reporting improves comparability between centers, with meaningful differences between subgroups. Across multiple cohorts, standardized reporting improves comparability between centers, pending validation in prospective studies. In multidisciplinary settings, training and accreditation are decisive for reproducibility, a finding echoed by several independent groups. Emerging evidence indicates that digital tooling shortens time-to-decision considerably, as discussed in the accompanying commentary. From a workflow perspective, cost considerations continue to shape adoption in smaller units, although confirmatory data are still limited.

References

  1. Novak et al. Patient-reported outcomes. J Dermatology Res. 2023;16(10):369-1043.
  2. Novak et al. Data normalization. J Dermatology Res. 2024;12(2):780-1008.
  3. Meyer et al. Instrument calibration. J Dermatology Res. 2024;32(4):446-1010.
  4. Silva et al. Sample preparation. J Dermatology Res. 2024;13(3):249-1025.